Via practica 6/2011
Early diagnostic of chronic obstructive pulmonary disease, therapy and their pharmacoeconomy profits
Chronic obstructive pulmonary disease (COPD) is currently the fourth cause of mortality in the world and it is predicted to rank third in the year 2020. The prevalence of COPD varies in different regions of the world, but it affects at least 10 % of the adult population. Despite being a chronic disease, that can not be cured, it is preventable disease (reducing tobacco consumption mostly) and treatable. We are indeed capable to improve many manifestation of disease, including symptoms, exacerbations, health status and prognosis.
Keywords: COPD, diagnostic, therapy, exacerbation, farmacoeconomy
